Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at USD 396 million in 2022 and is forecast to a readjusted size of USD 1015.7 million by 2029 with a CAGR of 14.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core human milk oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%. North America is the largest market, with a share about 45%, followed by Europe and China with the share about 32% and 10%.In terms of product, 2'-FL & 3-FL is the largest segment, with a share over 95%. And in terms of application, the largest application is infant formula.
This report is a detailed and comprehensive analysis for global Human Milk Oligosaccharides (HMO) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Milk Oligosaccharides (HMO) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Human Milk Oligosaccharides (HMO) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Human Milk Oligosaccharides (HMO) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (USD/Kg), 2018-2029
Global Human Milk Oligosaccharides (HMO) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Milk Oligosaccharides (HMO)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Milk Oligosaccharides (HMO) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein) and ZuChem and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Market segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others
Major players covered
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
ZuChem
Glycom
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Milk Oligosaccharides (HMO), with price, sales, revenue and global market share of Human Milk Oligosaccharides (HMO) from 2018 to 2023.
Chapter 3, the Human Milk Oligosaccharides (HMO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Milk Oligosaccharides (HMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Milk Oligosaccharides (HMO) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Milk Oligosaccharides (HMO).
Chapter 14 and 15, to describe Human Milk Oligosaccharides (HMO) sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Human Milk Oligosaccharides (HMO) . Industry analysis & Market Report on Human Milk Oligosaccharides (HMO) is a syndicated market report, published as Global Human Milk Oligosaccharides (HMO) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Human Milk Oligosaccharides (HMO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.